Martin Hellriegel

1.1k total citations
15 papers, 372 citations indexed

About

Martin Hellriegel is a scholar working on Obstetrics and Gynecology, Cancer Research and Oncology. According to data from OpenAlex, Martin Hellriegel has authored 15 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Obstetrics and Gynecology, 5 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Martin Hellriegel's work include Endometrial and Cervical Cancer Treatments (5 papers), Cervical Cancer and HPV Research (3 papers) and Ovarian cancer diagnosis and treatment (3 papers). Martin Hellriegel is often cited by papers focused on Endometrial and Cervical Cancer Treatments (5 papers), Cervical Cancer and HPV Research (3 papers) and Ovarian cancer diagnosis and treatment (3 papers). Martin Hellriegel collaborates with scholars based in Germany, United States and Netherlands. Martin Hellriegel's co-authors include Bernd Hinzmann, Christine Sers, Oleg Tchernitsa, Reinhold Schäfer, André Rosenthal, Johannes Zuber, Carsten Gründker, Günter Emons, G. Emons and Uwe Fischer and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Martin Hellriegel

11 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Hellriegel Germany 8 227 104 62 39 35 15 372
Iris Kufferath Austria 8 265 1.2× 68 0.7× 45 0.7× 66 1.7× 35 1.0× 11 396
Haruko Kunitomi Japan 9 183 0.8× 71 0.7× 112 1.8× 24 0.6× 23 0.7× 17 311
Dongyi Wan China 10 326 1.4× 153 1.5× 146 2.4× 50 1.3× 29 0.8× 16 481
Mitsuyo Yoshida Japan 12 167 0.7× 121 1.2× 108 1.7× 30 0.8× 9 0.3× 20 354
Elizabeth A. Loughran United States 7 202 0.9× 132 1.3× 90 1.5× 61 1.6× 19 0.5× 9 393
Dilys T.H. Leung Australia 9 177 0.8× 77 0.7× 110 1.8× 14 0.4× 38 1.1× 10 340
Sudha Desai United Kingdom 9 148 0.7× 88 0.8× 31 0.5× 21 0.5× 8 0.2× 15 304
Gudrun Hager Austria 11 171 0.8× 110 1.1× 109 1.8× 26 0.7× 23 0.7× 14 354
Ryan H. Livengood United States 8 172 0.8× 83 0.8× 53 0.9× 68 1.7× 25 0.7× 17 301
С. В. Айдагулова Russia 11 238 1.0× 55 0.5× 82 1.3× 160 4.1× 17 0.5× 75 439

Countries citing papers authored by Martin Hellriegel

Since Specialization
Citations

This map shows the geographic impact of Martin Hellriegel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Hellriegel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Hellriegel more than expected).

Fields of papers citing papers by Martin Hellriegel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Hellriegel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Hellriegel. The network helps show where Martin Hellriegel may publish in the future.

Co-authorship network of co-authors of Martin Hellriegel

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Hellriegel. A scholar is included among the top collaborators of Martin Hellriegel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Hellriegel. Martin Hellriegel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Erdemoğlu, Evrim, Pesach Lichtenberg, Mustafa Zelal Muallem, et al.. (2019). A GCIG international survey: clinical practice patterns of sentinel lymph node biopsies in cervical cancer. Archives of Gynecology and Obstetrics. 300(1). 191–199. 16 indexed citations
2.
Klapdor, Rüdiger, Linn Wölber, Lars Hanker, et al.. (2019). Predictive factors for lymph node metastases in vulvar cancer. An analysis of the AGO-CaRE-1 multicenter study. Gynecologic Oncology. 154(3). 565–570. 12 indexed citations
3.
Woelber, Linn, Katharina Prieske, Christine zu Eulenburg, et al.. (2019). p53 and p16 expression profiles reveal three prognostically relevant subgroups in vulvar cancer: A TMA based study by the AGO-CaRE-translational study group.. Journal of Clinical Oncology. 37(15_suppl). 5592–5592. 6 indexed citations
4.
Wienbeck, Susanne, Johannes Uhlig, Uwe Fischer, et al.. (2019). Breast lesion size assessment in mastectomy specimens. Medicine. 98(37). e17082–e17082. 14 indexed citations
5.
Gründker, Carsten, et al.. (2019). Inhibition of aerobic glycolysis enhances the anti‐tumor efficacy of Zoptarelin Doxorubicin in triple‐negative breast cancer cells. Journal of obstetrics and gynaecology research. 45(7). 1334–1342. 8 indexed citations
6.
Hellriegel, Martin, et al.. (2017). Co-treatment of breast cancer cells with pharmacologic doses of 2-deoxy-D-glucose and metformin: Starving tumors. Oncology Reports. 37(4). 2418–2424. 29 indexed citations
7.
Eulenburg, Christine zu, Anna Suling, Petra Neuser, et al.. (2016). Propensity Scoring after Multiple Imputation in a Retrospective Study on Adjuvant Radiation Therapy in Lymph-Node Positive Vulvar Cancer. PLoS ONE. 11(11). e0165705–e0165705. 13 indexed citations
8.
9.
Hellriegel, Martin, Gerd Bauerschmitz, & Günter Emons. (2013). Palliative Therapie beim Mammakarzinom. 7(6). 407–422.
10.
Emons, Günter, Gerd Bauerschmitz, & Martin Hellriegel. (2013). Palliative Konzepte beim Ovarialkarzinom. 7(6). 423–434.
11.
Emons, Günter, et al.. (2012). Endokrine Therapie des Endometriumkarzinoms. Der Gynäkologe. 45(8). 608–612. 2 indexed citations
12.
Emons, Günter, et al.. (2009). Moderne Konzepte in der Behandlung des Endometriumkarzinoms. Der Pathologe. 30(4). 268–273. 2 indexed citations
13.
Emons, Günter, et al.. (2009). Systemtherapie beim Endometriumkarzinom. Der Onkologe. 15(9). 893–903. 1 indexed citations
14.
15.
Zuber, Johannes, Oleg Tchernitsa, Bernd Hinzmann, et al.. (2000). A genome-wide survey of RAS transformation targets. Nature Genetics. 24(2). 144–152. 241 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Iris Kufferath Breakdown of academic impact, for papers by Haruko Kunitomi Breakdown of academic impact, for papers by Dongyi Wan Breakdown of academic impact, for papers by Mitsuyo Yoshida Breakdown of academic impact, for papers by Elizabeth A. Loughran Breakdown of academic impact, for papers by Dilys T.H. Leung Breakdown of academic impact, for papers by Sudha Desai Breakdown of academic impact, for papers by Gudrun Hager Breakdown of academic impact, for papers by Ryan H. Livengood Breakdown of academic impact, for papers by С. В. Айдагулова
Rankless by CCL
2026